Literature DB >> 18614790

VEGF inhibition and renal thrombotic microangiopathy.

Pisut Katavetin, Paravee Katavetin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18614790     DOI： 10.1056/NEJMc080770

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  10 in total

1.  Phase I trial of bevacizumab plus escalated doses of sunitinib in patients with metastatic renal cell carcinoma.

Authors:  Darren R Feldman; Michael S Baum; Michelle S Ginsberg; Hani Hassoun; Carlos D Flombaum; Susanne Velasco; Patricia Fischer; Ellen Ronnen; Nicole Ishill; Sujata Patil; Robert J Motzer
Journal:  J Clin Oncol       Date:  2009-02-17       Impact factor: 44.544

2.  VEGF165b overexpression restores normal glomerular water permeability in VEGF164-overexpressing adult mice.

Authors:  Sebastian Oltean; Christopher R Neal; Athina Mavrou; Panisha Patel; Thomas Ahad; Chloe Alsop; Thomas Lee; Karen Sison; Yan Qiu; Steven J Harper; David O Bates; Andrew H J Salmon
Journal:  Am J Physiol Renal Physiol       Date:  2012-07-18

3.  Overexpression of VEGF165b in podocytes reduces glomerular permeability.

Authors:  Yan Qiu; Joanne Ferguson; Sebastian Oltean; Chris R Neal; Amit Kaura; Heather Bevan; Emma Wood; Leslie M Sage; Silvia Lanati; Dawid G Nowak; Andy H J Salmon; David Bates; Steve J Harper
Journal:  J Am Soc Nephrol       Date:  2010-08-05       Impact factor: 10.121

Review 4.  Podocyte dysfunction in atypical haemolytic uraemic syndrome.

Authors:  Marina Noris; Caterina Mele; Giuseppe Remuzzi
Journal:  Nat Rev Nephrol       Date:  2015-01-20       Impact factor: 28.314

5.  Angiogenesis and chronic kidney disease.

Authors:  Yohei Maeshima; Hirofumi Makino
Journal:  Fibrogenesis Tissue Repair       Date:  2010-08-05

Review 6.  Mechanisms and consequences of TGF-ß overexpression by podocytes in progressive podocyte disease.

Authors:  Hyun Soon Lee
Journal:  Cell Tissue Res       Date:  2011-05-04       Impact factor: 5.249

7.  Glomerular endothelial cell injury and focal segmental glomerulosclerosis lesion in idiopathic membranous nephropathy.

Authors:  Megumi Morita; Akiko Mii; Akira Shimizu; Fumihiko Yasuda; Jun Shoji; Yukinari Masuda; Ryuji Ohashi; Kiyotaka Nagahama; Tomohiro Kaneko; Shuichi Tsuruoka
Journal:  PLoS One       Date:  2015-04-15       Impact factor: 3.240

Review 8.  Antiangiogenic Therapy for Diabetic Nephropathy.

Authors:  Katsuyuki Tanabe; Yohei Maeshima; Yasufumi Sato; Jun Wada
Journal:  Biomed Res Int       Date:  2017-08-01       Impact factor: 3.411

9.  Pegylated Liposomal Doxorubicin and Kidney-Limited Thrombotic Microangiopathy in a Kidney Transplant Recipient: A Case Report.

Authors:  Sonia Rodriguez-Ramirez; Kevin Yau; Abhijat Kitchlu; Rohan John; April A N Rose; David Hogg; S Joseph Kim
Journal:  Kidney Med       Date:  2022-04-04

10.  Inverse correlation between vascular endothelial growth factor back-filtration and capillary filtration pressures.

Authors:  Christoph Kuppe; Wilko Rohlfs; Martin Grepl; Kevin Schulte; Delma Veron; Marlies Elger; Silja Kerstin Sanden; Turgay Saritas; Johanna Andrae; Christer Betsholtz; Christian Trautwein; Ralf Hausmann; Susan Quaggin; Sebastian Bachmann; Wilhelm Kriz; Alda Tufro; Jürgen Floege; Marcus J Moeller
Journal:  Nephrol Dial Transplant       Date:  2018-09-01       Impact factor: 5.992
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.